Free public records show Vectorious Medical Technologies Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Vectorious Medical Technologies Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Vectorious Medical Technologies Ltd., of 4 in all
Source: ClinicalTrials.gov, Studies with Vectorious Medical Technologies Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Vectorious Medical Technologies Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Vectorious Medical Technologies Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Vectorious Medical Technologies Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Vectorious Medical Technologies Ltd. is in.
Stories on the topics Vectorious Medical Technologies Ltd. works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
ReadSearch all reports for Vectorious Medical Technologies Ltd. All companies